CRL Q3'26 Earnings: revenue estimate is 960.36M USD

What happened

Charles River Laboratories will report Q3'26 results on November 04 before the market opens, at 7:00 AM ET. The revenue estimate is 960.36 million USD, and the earnings per share estimate is 2.97 USD.

Confirmed

Global impact / market context

The revenue estimate is lower than the figures shown for earlier quarters, so a miss against this reduced bar could point to slowing demand. That could pressure the stock and push investors to reassess growth expectations.

Analyst inference

The company beat revenue estimates in each of the four prior quarters shown and beat earnings per share estimates every time. That history raises expectations, so matching or missing the lowered revenue estimate could matter more than usual.

Analyst inference

What to watch

1. Watch the reported Q3'26 revenue against the 960.36 million USD estimate and earnings per share against 2.97 USD when results are released on November 04. Confirmed
2. Compare the reported revenue with the prior quarters shown to see whether the expected decline reflects a real slowdown or only cautious guidance. Analyst inference
3. Track whether the pattern of beating estimates continues, since four straight revenue beats and four straight earnings beats set a high bar for this report. Analyst inference

Evidence

• Original source link unavailable